Sales performance sequentially improved for fourth consecutive quarter Quarterly operating income growth for first time since 2021 Raises full year […]
BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) — Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies to treat […]